Oral medications with narrow therapeutic indices represent a primary concern
A patient on 2.4 mg of semaglutide weekly might reduce to 1.0 mg or even 0.5 mg for maintenance
En Vogue IV Therapy & Wellness follows evidence-based BMI standards, typically offering treatment to individuals with a BMI of 30+ or 27+ when paired with health concerns such as insulin resistance or high triglycerides
This overexposure pattern depletes intracellular antioxidants, disrupts redox balance and leads to adverse effects, including cell apoptosis, proliferation inhibition, and functional impairment
Some patients maintain their goal weight indefinitely on semaglutide, while others use it to reach a target and then transition to maintenance strategies
GLP-1 stands for glucagon-like peptide-1, a hormone your body releases naturally after meals